Investigating Eye-Movement Biomarkers of Disease Severity and Cognition in Multiple Sclerosis

Recruiting

Investigating Eye-Movement Biomarkers of Disease Severity and Cognition in Multiple Sclerosis

Sponsor:

Innodem Neurosciences

Code:

NCT05661266

Conditions

Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Eye-Tracking

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-07-15. This information was provided to ClinicalTrials.gov by Innodem Neurosciences on 2023-10-18.